| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Mehmud Faisal | Chief Medical Officer | 300 CONSHOHOCKEN STATE ROAD, SUITE 200, W. CONSHOHOCKEN | /s/ Raza Bokhari, as Attorney-in-Fact, for Faisal Mehmud | 24 Jul 2025 | 0002047946 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MDCX | Stock Option (right to buy) | Award | $0 | +50,000 | $0.000000 | 50,000 | 22 Jul 2025 | Common Shares | 50,000 | $3.08 | Direct | F3 | |
| holding | MDCX | Stock Option (right to buy) | 100,000 | 22 Jul 2025 | Common Shares | 100,000 | $2.26 | Direct | F1, F2 |
| Id | Content |
|---|---|
| F1 | Represents an exercise price of $3.25 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024. |
| F2 | The board of directors of Medicus Pharma Ltd. (the ?Board?) approved, during a Board meeting held on July 22, 2025, accelerated vesting of the Reporting Person's options that were otherwise unvested and scheduled to vest annually in five equal installments beginning on November 14, 2025. All these options are now vested. |
| F3 | The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year. |